Induction of an osteocyte-like phenotype by fibroblast growth factor-2

Biochemical and Biophysical Research Communications

Volumn 402, Issue 2, 2010, Pages 258-264

  Gupta, Rishi R ^a   Yoo, David J ^a   Hebert, Carla ^a   Niger, Corinne ^a   Stains, Joseph P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow stromal cell; Connexin43; Dentin matrix protein 1; Osteoblast; Osteocyte; Sclerostin

Indexed keywords

DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 2; MARKER; SCLEROSTIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL LINE; CELL LINEAGE; CELL STRUCTURE; DENDRITIC CELL; GENE; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHENOTYPE; PHEX GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; MICE; OSTEOBLASTS; OSTEOCYTES; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE;

EID: 78149466133     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.011     Document Type: Article

References (39)

1. Marie P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003, 316:23-32.
2. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002, 16:1446-1465.
3. Hurley M.M., Okada Y., Xiao L., Tanaka Y., Ito M., Okimoto N., Nakamura T., Rosen C.J., Doetschman T., Coffin J.D. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2 mice. Biochem. Biophys. Res. Commun. 2006, 341:989-994.
4. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman T., Coffin J.D., Hurley M.M. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 2000, 105:1085-1093.
5. Sabbieti M.G., Agas D., Xiao L., Marchetti L., Coffin J.D., Doetschman T., Hurley M.M. Endogenous FGF-2 is critically important in PTH anabolic effects on bone. J. Cell Physiol. 2009, 219:143-151.
6. Naganawa T., Xiao L., Abogunde E., Sobue T., Kalajzic I., Sabbieti M., Agas D., Hurley M.M. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. Biochem. Biophys. Res. Commun. 2006, 339:490-498.
7. Xiao L., Liu P., Li X., Doetschman T., Coffin J.D., Drissi H., Hurley M.M. Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice. J. Biol. Chem. 2009, 284:3170-3182.
8. Nagai H., Tsukuda R., Mayahara H. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 1995, 16:367-373.
9. Nakamura T., Hanada K., Tamura M., Shibanushi T., Nigi H., Tagawa M., Fukumoto S., Matsumoto T. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995, 136:1276-1284.
10. Liang H., Pun S., Wronski T.J. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology 1999, 140:5780-5788.
11. Pun S., Florio C.L., Wronski T.J. Anabolic effects of basic fibroblast growth factor in the tibial diaphysis of ovariectomized rats. Bone 2000, 27:197-202.
12. Nakamura T., Hara Y., Tagawa M., Tamura M., Yuge T., Fukuda H., Nigi H. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J. Bone Miner. Res. 1998, 13:942-949.
13. Radomsky M.L., Aufdemorte T.B., Swain L.D., Fox W.C., Spiro R.C., Poser J.W. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J. Orthop. Res. 1999, 17:607-614.
14. Radomsky M.L., Thompson A.Y., Spiro R.C., Poser J.W. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin. Orthop. Relat. Res. 1998, S283-S293.
15. Rodan S.B., Wesolowski G., Yoon K., Rodan G.A. Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J. Biol. Chem. 1989, 264:19934-19941.
16. Hurley M.M., Abreu C., Harrison J.R., Lichtler A.C., Raisz L.G., Kream B.E. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 1993, 268:5588-5593.
17. Debiais F., Hott M., Graulet A.M., Marie P.J. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J. Bone Miner. Res. 1998, 13:645-654.
18. Noble B.S. The osteocyte lineage. Arch. Biochem. Biophys. 2008, 473:106-111.
19. G.Y. Rochefort, S. Pallu, C.L. Benhamou, Osteocyte: the unrecognized side of bone tissue, Osteoporos. Int.
20. Bonewald L.F. Osteocyte messages from a bony tomb. Cell Metab. 2007, 5:410-411.
21. Castro C.H., Shin C.S., Stains J.P., Cheng S.L., Sheikh S., Mbalaviele G., Szejnfeld V.L., Civitelli R. Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J. Cell Sci. 2004, 117:2853-2864.
22. Kato Y., Windle J.J., Koop B.A., Mundy G.R., Bonewald L.F. Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Miner. Res. 1997, 12:2014-2023.
23. Lima F., Niger C., Hebert C., Stains J.P. Connexin43 potentiates osteoblast responsiveness to fibroblast growth factor 2 via a protein kinase C-delta/Runx2-dependent mechanism. Mol. Biol. Cell 2009, 20:2697-2708.
24. Stains J.P., Weber J.A., Gay C.V. Expression of Na(+)/Ca(2+) exchanger isoforms (NCX1 and NCX3) and plasma membrane Ca(2+) ATPase during osteoblast differentiation. J. Cell Biochem. 2002, 84:625-635.
25. Niger C., Howell F.D., Stains J.P. Interleukin-1beta increases gap junctional communication among synovial fibroblasts via the extracellular signal regulated kinase pathway. Biol. Cell 2009.
26. Chung D.J., Castro C.H., Watkins M., Stains J.P., Chung M.Y., Szejnfeld V.L., Willecke K., Theis M., Civitelli R. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J. Cell Sci. 2006, 119:4187-4198.
27. Wang D., Christensen K., Chawla K., Xiao G., Krebsbach P.H., Franceschi R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J. Bone Miner. Res. 1999, 14:893-903.
28. Xiao G., Jiang D., Gopalakrishnan R., Franceschi R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J. Biol. Chem. 2002, 277:36181-36187.
29. Becker J., Schuppan D., Benzian H., Bals T., Hahn E.G., Cantaluppi C., Reichart P. Immunohistochemical distribution of collagens types IV, V, and VI and of pro-collagens types I and III in human alveolar bone and dentine. J. Histochem. Cytochem. 1986, 34:1417-1429.
30. Mikuni-Takagaki Y., Kakai Y., Satoyoshi M., Kawano E., Suzuki Y., Kawase T., Saito S. Matrix mineralization and the differentiation of osteocyte-like cells in culture. J. Bone Miner. Res. 1995, 10:231-242.
31. Sandberg M., Autio-Harmainen H., Vuorio E. Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-fos genes in developing human calvarial bones. Dev. Biol. 1988, 130:324-334.
32. Toyosawa S., Shintani S., Fujiwara T., Ooshima T., Sato A., Ijuhin N., Komori T. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J. Bone Miner. Res. 2001, 16:2017-2026.
33. Feng J.Q., Ward L.M., Liu S., Lu Y., Xie Y., Yuan B., Yu X., Rauch F., Davis S.I., Zhang S., Rios H., Drezner M.K., Quarles L.D., Bonewald L.F., White K.E. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat. Genet. 2006, 38:1310-1315.
34. Zhang K., Barragan-Adjemian C., Ye L., Kotha S., Dallas M., Lu Y., Zhao S., Harris M., Harris S.E., Feng J.Q., Bonewald L.F. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol. Cell Biol. 2006, 26:4539-4552.
35. Civitelli R. Cell-cell communication in the osteoblast/osteocyte lineage. Arch. Biochem. Biophys. 2008, 473:188-192.
36. Jiang J.X., Siller-Jackson A.J., Burra S. Roles of gap junctions and hemichannels in bone cell functions and in signal transmission of mechanical stress. Front Biosci. 2007, 12:1450-1462.
37. Stains J.P., Civitelli R. Gap junctions in skeletal development and function. Biochim. Biophys. Acta 2005, 1719:69-81.
38. Strom T.M., Juppner H. PHEX, FGF23, DMP1 and beyond. Curr. Opin. Nephrol. Hypertens. 2008, 17:357-362.
39. Poole K.E., van Bezooijen R.L., Loveridge N., Hamersma H., Papapoulos S.E., Lowik C.W., Reeve J. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005, 19:1842-1844.